All supplements

Supplement evidence

178 / 575Research index — evidence review pending

Aspartate

View my plan

The short answer

No use has passed JIVANA's study-level evidence review yet.

Evidence and scope
Research gathered — evidence review pending

This status does not grade the ingredient for every goal, outcome, or person.

Important limitation
No efficacy conclusion has passed JIVANA's study-level review yet. The linked research index is for discovery, not a benefit claim.
Before deciding
Identity, dose, interactions, product quality, and regulatory status still require review. Do not use this provisional page to decide whether to take it.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

Study-level extraction is not complete yet.

This research-index page is live so the topic, source trail, and evidence boundaries are visible. Individual studies have not yet passed the JIVANA extraction and review process, so we do not manufacture an efficacy conclusion or research count from broad search results.

Unscreened discovery appendix—not evidence4,630 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.
  1. Efficacy and hepatotoxicity of Psoralea corylifolia L.: A meta-analysis and machine learning assessment in postmenopausal osteoporosis.Yang H, Tang R, Ren Y et al. · 2026 · Journal of ethnopharmacology · PMID 42331197Open on PubMed
  2. Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial.Katrevula A, Kalapala R, Agrawal S et al. · 2026 · Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · PMID 41066034Open on PubMed
  3. Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.Wu YL, Hochmair M, Yang Y et al. · 2026 · The New England journal of medicine · PMID 42223087Open on PubMed
  4. Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial.Giesen LFP, Roest JA, Koopman FMA et al. · 2026 · Clinical chemistry · PMID 41967464Open on PubMed
  5. Population Pharmacokinetics and Exposure-Response Analyses of Vepdegestrant, a First-in-Class PROteolysis-TArgeting Chimera Estrogen Receptor Degrader.Yang DZ, Masters JC, Wang H et al. · 2026 · Journal of clinical pharmacology · PMID 42572241Open on PubMed
  6. Ovarian teratoma and the anti-N-methyl-D-aspartate receptor encephalitis paraneoplastic phenomenon: A systematic review and analysis of the literature.Conway D, Dufour L, Lockley M et al. · 2026 · Surgical oncology · PMID 42361457Open on PubMed
  7. Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.Merle P, Blanc JF, Le Malicot K et al. · 2026 · The lancet. Gastroenterology & hepatology · PMID 42330996Open on PubMed
  8. A phase 1 study of PF-07260437, a B7-H4 × CD3 bispecific T-cell engager, in patients with advanced or metastatic breast, ovarian, and endometrial cancer.Yan F, Cruz-Correa M, Specht J et al. · 2026 · Investigational new drugs · PMID 42171881Open on PubMed
  9. Safety of 8-Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi-Center, Double-Blinded, Placebo-Controlled Study.Pakhale K, Salve J, Ademola J et al. · 2026 · Phytotherapy research : PTR · PMID 41943502Open on PubMed
  10. Risk factors for hepatic failure after transarterial chemoembolization in patients with hepatocellular carcinoma: a systematic review and meta-analysis.Prasitsumrit V, Thiravetyan B, Sodsri T et al. · 2026 · European journal of gastroenterology & hepatology · PMID 41604560Open on PubMed
  11. Lead-induced neurotoxic effects on the synaptic signalling pathways and its association with autism spectrum disorder: a systematic review.Nair G, Adhikary S, Harshitha P et al. · 2026 · International journal of environmental health research · PMID 41486071Open on PubMed
  12. The Effect of a Ketogenic Diet on Liver Health: A Systematic Review and Meta-Analysis.Qu Y, Sohouli MH, Rohani P et al. · 2026 · Nutrition reviews · PMID 41206623Open on PubMed

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.

Educational information only—not medical advice. Product quality, dose, medicines, pregnancy, and kidney or liver disease can materially change safety.